How We Do It
The DevPro Biopharma methodology begins with Identifying the Right Targets. Our team then utilizes the DevPro Biopharma Clinical internal execution platform
Our Services
Clinical Development Offerings
Clients engage the experienced DevPro Biopharma team to design, develop, and execute programs.
Clinical Development offerings might include:
- Clinical development strategy and plan
- Regulatory strategy and plan
- Execution strategy planning and validation
- Perform global regulatory submissions (NDAs, etc.)
- Lead global regulatory inspections
Advisory Services
Clients leverage our team’s experience and expertise to advise them. Such services might include:
- Due diligence and validation of investment ideas
- Risk assessments and review of development projects
- Advisors for development projects and new product development ideas
- Advisory boards for new product development ideas or indications
Clinical investment offerings might include:
- o Sourcing of capital investments to fund development programs
- Enable asset out-licensing, acquisition, and spin-outs
- Provide turn-key clinical development infrastructure
How We Add Value
At the start of an engagement, the DevPro Biopharma team implements a comprehensive review of the asset’s design, development, and delivery strategies.
Clients get the benefit of the experienced DevPro Biopharma team, and reduce the need to hire, onboard, and develop multiple internal functions. Our team will design, develop, and deliver an efficient clinical program to support regional or global registration.
With the DevPro Biopharma Clinical Internal Execution Platform clients can leverage one ecosystem which includes our established network of experienced partners. Further, clients take advantage of our well-tested, proven processes and technologies designed to deliver turn-key clinical internal execution platform, including tools that reduce potential for errors, simplify and streamline data entry, collection, and critical-to-quality controls.
Key Drivers
- Highest Quality and Ethics
- Reduced Cycle Time
- Flexibility and Agility
- Cost Containment
- Best of Breed Partners
